Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnostic Performance of Spot Urine Sample for the Monoclonal Components Detection in Patients With Multiple Myeloma RHU(M)M Random or H24 Urine in (Multiple) Myeloma

NCT05208086 is registered in ClinicalTrials.gov with Intergroupe Francophone du Myelome as lead sponsor.

NCT NCT05208086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05208086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnostic Performance of Spot Urine Sample for the Monoclonal Components Detection in Patients With Multiple Myeloma RHU(M)M Random or H24 Urine in (Multiple) Myeloma
Lead sponsor
Intergroupe Francophone du Myelome
Phase
Observational
Overall status
Active, not recruiting
Start date
May 18, 2022
Completion date
May 31, 2026
Enrollment
180 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma